7 November 2014 in Neurological Research
It is still unclear as to why multiple sclerosis (MS) is so devastating and rapidly progressive in one patient and less so in another. Recent data implicate vitamin D in modulation of the risk as well as the clinical course of disease. Since vitamin D acts through the vitamin D receptor (VDR), association of single nucleotide polymorphisms (SNPs) in the VDR gene might account for variations in the MS risk within populations. The aim of our study was to determine the association between FokI gene polymorphism (rs10735810) and the risk of MS in a cohort of Slovak population and to investigate possible correlations of this SNP with the rate of disease disability progression. FokI SNP was detected in 270 clinically diagnosed MS patients and 303 healthy control subjects. Genotyping was performed by polymerase chain reaction (PCR) and restriction analysis. We used multiple sclerosis severity score (MSSS) for patient's stratification by the rate of disease disability progression. We observed a significantly higher frequency of Ff genotype of FokI SNP (53·4 vs 43·7%, P = 0·042) in women with MS compared to women of the control group. There was no significant association between FokI SNP and the rate of disease disability progression. Although our findings suggest a weak association between VDR SNP FokI and the MS risk in women, further studies are needed to explore the role of VDR polymorphic alterations in MS disease etiology and pathogenesis.
1 May 2015 in Journal of Neuroimmunology
27 July 2021 in Neurological Research
Multiple sclerosis (MS) is an inflammatory demyelinating disease that may cause physical disabling as well as cognitive dysfunction. The presented study investigated how the neuropsychological stat...
10 September 2026 in Current Molecular Medicine
Introduction: Circulating tumor DNA is a promising noninvasive tool for tumor genotyping and recurrence monitoring in Colorectal Cancer (CRC), but its role in nonmetastatic disease remains unclear. This cross-sectional study evaluated preoperative plasma circulating cell-free DNA (cfDNA) in patients undergoing complete mesocolic excision (CME) with D3 lymphadenectomy. Methods: Preoperative plasma samples were collected from 32 patients with predominantly right-sided CRC; 31 with histologically confirmed malignancy were analysed. cfDNA was sequenced using the AVENIO ctDNA Expanded Panel targeting 77 cancer-related genes. Sequencing metrics, Variant Allele Frequency (VAF), variant types, and cfDNA variants were evaluated. Results: High-quality cfDNA was obtained from all patients (mean yield 0.69 ng/μL). Sequencing met performance criteria (>22 million read pairs, >86% mapped reads, depth 6779×/3523×). Variants were detected in 74% of the patients, most frequently in TP53 (n=11), APC (n=8) and KRAS (n=7). The mean VAF was 0.8%, with some variants exceeding 20%. The most frequent hotspot was KRAS c.38G>A (p.Gly13Asp) (n=4). Recurrent variants were observed in IDH2, MET, GNAS, CTNNB1, and PDCD1LG2, indicating molecular heterogeneity. Discussion: Preoperative tumor-naïve cfDNA sequencing enabled detection of established CRC driver alterations and rare variants, supporting its potential for minimally invasive molecular characterization. Compared with tumor-informed approaches, this strategy allows plasma profiling without prior tissue sequencing; however, variant interpretation remains limited without matched tumor and white blood cell DNA. Conclusion: Targeted cfDNA sequencing is feasible in preoperative CRC patients undergoing CME and provides a molecular baseline for future perioperative studies. Larger prospective cohorts with longitudinal follow-up are required to define its prognostic and clinical utility.
22 June 2026 in Zdravotnícke štúdie
Introduction: Tuberculosis (TB) in the pediatric population remains a major diagnostic challenge. Alterations in iron metabolism, including changes in ferritin and transferrin levels, may reflect not only the host inflammatory response but also iron availability for Mycobacterium tuberculosis (Mtb). The aim of this study was to compare plasma ferritin and transferrin concentrations in pediatric patients with different forms of TB and in controls. Methods: A total of 145 pediatric patients with TB or suspected TB hospitalized at pediatric departments in Dolný Smokovec, Slovakia, and Prague between 2024 and 2025 were included in the study. Plasma ferritin and transferrin concentrations were measured in these patients. The patients were divided into four groups: bacteriologically confirmed TB (bact. TB; n = 22), clinically confirmed TB (clin. TB; n = 36), tuberculosis infection (TBI; n = 29), and controls (n = 58). Results: Transferrin levels were significantly decreased in patients with bact. TB compared with the other groups. In contrast, ferritin concentrations did not differ significantly among the groups, although higher levels were observed in the bact. TB group. These findings reflect differing patterns of ferritin and transferrin in association with active disease. Conclusion: Transferrin and ferritin may be useful biomarkers of TB in pediatric patients, with transferrin appearing to have greater diagnostic potential in our cohort. Since both parameters may reflect not only TB-related processes but also alterations in iron metabolism and the inflammatory response, their diagnostic value may be enhanced when evaluated in combination with other biomarkers.